Bioventus Acquires Bioness, Inc.
30 mars 2021 17h41 HE
|
Bioventus, Inc.
DURHAM, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc....
Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance
25 mars 2021 16h05 HE
|
Bioventus, Inc.
DURHAM, N.C., March 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for...
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS™ (PTP-001) for the Treatment of Knee OA
11 mars 2021 09h00 HE
|
Bioventus, Inc.
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported that the first patients have been...
Larry Chen Joins Bioventus as Managing Director, China and Asia Pacific
04 mars 2021 09h00 HE
|
Bioventus, Inc.
DURHAM, N.C., March 04, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Larry Chen as Managing...
Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
01 mars 2021 16h05 HE
|
Bioventus, Inc.
DURHAM, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that fourth quarter...
Bioventus Announces Pricing of Initial Public Offering
10 févr. 2021 23h09 HE
|
Bioventus, Inc.
DURHAM, N.C., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock...